ECSP992905A - PHARMACEUTICAL COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF MALARIA - Google Patents
PHARMACEUTICAL COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF MALARIAInfo
- Publication number
- ECSP992905A ECSP992905A ECSP992905A ECSP992905A EC SP992905 A ECSP992905 A EC SP992905A EC SP992905 A ECSP992905 A EC SP992905A EC SP992905 A ECSP992905 A EC SP992905A
- Authority
- EC
- Ecuador
- Prior art keywords
- malaria
- present
- compositions
- treatment
- compounds
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención se refiere a compuestos y composiciones farmacéuticas que inhiben proteasas, tales como las proteasas de cisteína. En particular, la presente invención se refiere a compuestos y composiciones farmacéuticas que inhiben proteasas de cisteína de la superfamilia de la papaína. Los compuestos y composiciones farmacéuticas de la presente inevnción son útiles para tratar enfermedades, en particular enfermedades parasitarias, que son medidas por tales proteasas. En particular, la presente invención se refiere a un método para tratar la malaria inhibiendo la proteasa de cisteina, falcipaína.The present invention relates to compounds and pharmaceutical compositions that inhibit proteases, such as cysteine proteases. In particular, the present invention relates to compounds and pharmaceutical compositions that inhibit cysteine proteases of the papain superfamily. The compounds and pharmaceutical compositions of the present invention are useful for treating diseases, in particular parasitic diseases, that are measured by such proteases. In particular, the present invention relates to a method of treating malaria by inhibiting the cysteine protease, falcipain.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP992905 ECSP992905A (en) | 1999-04-05 | 1999-04-05 | PHARMACEUTICAL COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF MALARIA |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP992905 ECSP992905A (en) | 1999-04-05 | 1999-04-05 | PHARMACEUTICAL COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF MALARIA |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP992905A true ECSP992905A (en) | 1999-08-12 |
Family
ID=42043894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP992905 ECSP992905A (en) | 1999-04-05 | 1999-04-05 | PHARMACEUTICAL COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF MALARIA |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP992905A (en) |
-
1999
- 1999-04-05 EC ECSP992905 patent/ECSP992905A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY27234A1 (en) | NOVELTY INHIBITORS OF TYROSINE KINASE | |
| UY28215A1 (en) | USEFUL KINAZOLINES AS IONIC CHANNEL MODULATORS | |
| GT200500007A (en) | [1,8] NAFTIRIDIN-2-WAVES AND RELATED COMPOUNDS FOR THE TREATMENT OF CHICHOPHRENIA. | |
| UY27774A1 (en) | METALOPROTEIN INHIBITORS OF TRIARIL-OXI-ARIL-ESPIROPIRIMIDINA-2,4,6-TRIONA | |
| UY27872A1 (en) | CASPASA INHIBITORS AND USES OF THE SAME. | |
| PA8493701A1 (en) | COMPOUNDS TO TREAT OBESITY | |
| CR9465A (en) | PHARMACOCINETICALLY IMPROVED COMPOUNDS | |
| CL2004000849A1 (en) | COMPOUNDS DERIVED FROM BENZAMIDAS-2-HIDROXI-3-DIAMINOALCANS, USEFUL FOR THE TREATMENT OR PREVENTION OF ALZHEIMER, DOWN SYNDROME, HEREDITARY CEREBRAL HEMORRAGY, DEGENERATIVE DEMENCIES AND OTHERS. | |
| PA8621901A1 (en) | SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES | |
| ECSP055719A (en) | TIAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS | |
| TR200002940T2 (en) | Treatment of diseases caused by parasites by inhibition of cysteine proteases from the papain superfamily | |
| UY28098A1 (en) | USEFUL ANILINOPIRAZOL DERIVATIVES IN THE TREATMENT OF DIABETES | |
| UY28333A1 (en) | CASPASA INHIBITORS AND THEIR USES. | |
| UY30220A1 (en) | TETRAHYDROPIRIDOTIENOPIRIMIDINA COMPOUNDS AND METHODS FOR USE | |
| PA8604201A1 (en) | USED 2-AMINO-PYRIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES | |
| DK1641803T3 (en) | Thienopyrimidine derivatives as potassium channel inhibitors | |
| PA8603001A1 (en) | USEFUL COMPOUNDS FOR THE TREATMENT OF DISEASES | |
| EE200400031A (en) | A composition of biochemical compounds, its use for inhibiting matrix metalloproteinases, and a pharmaceutical formulation containing it | |
| BRPI0408299A (en) | cathepsin inhibitors s | |
| UY27733A1 (en) | CYCLOPENTENE DERIVATIVES | |
| ECSP992905A (en) | PHARMACEUTICAL COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF MALARIA | |
| ECSP055917A (en) | DERIVATIVES OF USEFUL DIAZEPANES AS LFA INHIBITORS | |
| PA8579401A1 (en) | DERIVATIVES OF 2,3-DIHIDRO-ISOINDOL-1-ONA AS MAO-B INHIBITORS | |
| BRPI0414423A (en) | pace4 inhibitors, their pharmaceutical compositions and their uses | |
| BR9909530A (en) | Treatment of parasitic diseases by inhibiting papaya superfamily cysteine proteases |